These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16801421)

  • 1. The antimalarial artemisinin synergizes with antibiotics to protect against lethal live Escherichia coli challenge by decreasing proinflammatory cytokine release.
    Wang J; Zhou H; Zheng J; Cheng J; Liu W; Ding G; Wang L; Luo P; Lu Y; Cao H; Yu S; Li B; Zhang L
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2420-7. PubMed ID: 16801421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation.
    Li B; Zhang R; Li J; Zhang L; Ding G; Luo P; He S; Dong Y; Jiang W; Lu Y; Cao H; Zheng J; Zhou H
    Int Immunopharmacol; 2008 Mar; 8(3):379-89. PubMed ID: 18279792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chloroquine protects mice from challenge with CpG ODN and LPS by decreasing proinflammatory cytokine release.
    Hong Z; Jiang Z; Liangxi W; Guofu D; Ping L; Yongling L; Wendong P; Minghai W
    Int Immunopharmacol; 2004 Feb; 4(2):223-34. PubMed ID: 14996414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting CpG DNA to screen and isolate anti-sepsis fraction and monomers from traditional Chinese herbs using affinity biosensor technology.
    Liu X; Cheng J; Zheng X; Chen Y; Wu C; Li B; Fu J; Cao H; Lu Y; Li J; Zheng J; Zhou H
    Int Immunopharmacol; 2009 Aug; 9(9):1021-31. PubMed ID: 19376273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The newly identified CpG-N ODN208 protects mice from challenge with CpG-S ODN by decreasing TNF-alpha release.
    Wang L; Jiang W; Ding G; Cao H; Lu Y; Luo P; Zhou H; Zheng J
    Int Immunopharmacol; 2007 May; 7(5):646-55. PubMed ID: 17386412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy of 15-epi-lipoxin A4 with antibiotics protects mice from Escherichia coli-induced sepsis*.
    Ueda T; Fukunaga K; Seki H; Miyata J; Arita M; Miyasho T; Obata T; Asano K; Betsuyaku T; Takeda J
    Crit Care Med; 2014 Apr; 42(4):e288-95. PubMed ID: 24463858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Therapeutic Antibiotics, Probiotics, and Synthetic CpG-ODNs for Protective Efficacy Against
    Gunawardana T; Ahmed KA; Popowich S; Kurukulasuriya S; Lockerbie B; Karunarathana R; Ayalew LE; Liu M; Tikoo SK; Gomis S
    Avian Dis; 2022 Jun; 66(2):165-175. PubMed ID: 35723931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic CpG-ODN rapidly enriches immune compartments in neonatal chicks to induce protective immunity against bacterial infections.
    Gunawardana T; Ahmed KA; Goonewardene K; Popowich S; Kurukulasuriya S; Karunarathna R; Gupta A; Lockerbie B; Foldvari M; Tikoo SK; Willson P; Gomis S
    Sci Rep; 2019 Jan; 9(1):341. PubMed ID: 30674918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An anti-sepsis monomer, 2',5,6',7-tetrahydroxyflavanonol (THF), identified from Scutellaria baicalensis Georgi neutralizes lipopolysaccharide in vitro and in vivo.
    Fu J; Cao H; Wang N; Zheng X; Lu Y; Liu X; Yang D; Li B; Zheng J; Zhou H
    Int Immunopharmacol; 2008 Dec; 8(12):1652-7. PubMed ID: 18755299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preexposure of murine macrophages to CpG oligonucleotide results in a biphasic tumor necrosis factor alpha response to subsequent lipopolysaccharide challenge.
    Crabtree TD; Jin L; Raymond DP; Pelletier SJ; Houlgrave CW; Gleason TG; Pruett TL; Sawyer RG
    Infect Immun; 2001 Apr; 69(4):2123-9. PubMed ID: 11254566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal delivery of CpG-ODN mimicking bacterial DNA via the intrapulmonary route induces systemic antimicrobial immune responses in neonatal chicks.
    Goonewardene K; Ahmed KA; Gunawardana T; Popowich S; Kurukulasuriya S; Karunarathna R; Gupta A; Ayalew LE; Lockerbie B; Foldvari M; Tikoo S; Willson P; Gomis S
    Sci Rep; 2020 Mar; 10(1):5343. PubMed ID: 32210244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased intracellular TLR9 confers hyporesponsiveness of RAW264.7 cells to subsequent CpG ODN challenge.
    Wei L; Hong Z; Jiang Z; Guofu D; Hongwei C; Liangxi W; Yongling L; Bin L; Ping L
    Int Immunopharmacol; 2006 Jun; 6(6):935-46. PubMed ID: 16644479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of chickens against Escherichia coli infections by DNA containing CpG motifs.
    Gomis S; Babiuk L; Godson DL; Allan B; Thrush T; Townsend H; Willson P; Waters E; Hecker R; Potter A
    Infect Immun; 2003 Feb; 71(2):857-63. PubMed ID: 12540567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artesunate in combination with oxacillin protect sepsis model mice challenged with lethal live methicillin-resistant Staphylococcus aureus (MRSA) via its inhibition on proinflammatory cytokines release and enhancement on antibacterial activity of oxacillin.
    Jiang W; Li B; Zheng X; Liu X; Cen Y; Li J; Pan X; Cao H; Zheng J; Zhou H
    Int Immunopharmacol; 2011 Aug; 11(8):1065-73. PubMed ID: 21396483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG-oligodeoxynucleotide-induced TLR9 activation regulates macrophage TREM-1 expression and shedding.
    Molad Y; Pokroy-Shapira E; Carmon V
    Innate Immun; 2013 Dec; 19(6):623-30. PubMed ID: 23475790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of chickens against a lethal challenge of Escherichia coli by a vaccine containing CpG oligodeoxynucleotides as an adjuvant.
    Gomis S; Babiuk L; Allan B; Willson P; Waters E; Hecker R; Potter A
    Avian Dis; 2007 Mar; 51(1):78-83. PubMed ID: 17461270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artesunate protects sepsis model mice challenged with Staphylococcus aureus by decreasing TNF-alpha release via inhibition TLR2 and Nod2 mRNA expressions and transcription factor NF-kappaB activation.
    Li B; Li J; Pan X; Ding G; Cao H; Jiang W; Zheng J; Zhou H
    Int Immunopharmacol; 2010 Mar; 10(3):344-50. PubMed ID: 20005985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic Human TLR9-LRR11 Peptide Attenuates TLR9 Signaling by Binding to and thus Decreasing Internalization of CpG Oligodeoxynucleotides.
    Pan X; Li B; Kuang M; Liu X; Cen Y; Qin R; Ding G; Zheng J; Zhou H
    Int J Mol Sci; 2016 Feb; 17(2):242. PubMed ID: 26907260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrapulmonary Delivery of CpG-ODN Microdroplets Provides Protection Against Escherichia coli Septicemia in Neonatal Broiler Chickens.
    Goonewardene KB; Popowich S; Gunawardana T; Gupta A; Kurukulasuriya S; Karunarathna R; Chow-Lockerbie B; Ahmed KA; Tikoo SK; Foldvari M; Willson P; Gomis S
    Avian Dis; 2017 Dec; 61(4):503-511. PubMed ID: 29337617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual targets guided screening and isolation of Kukoamine B as a novel natural anti-sepsis agent from traditional Chinese herb Cortex lycii.
    Liu X; Zheng X; Long Y; Cao H; Wang N; Lu Y; Zhao K; Zhou H; Zheng J
    Int Immunopharmacol; 2011 Jan; 11(1):110-20. PubMed ID: 21073991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.